Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Dr. Deng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
West China University of Medical SciencesClass of 2015
Certifications & Licensure
WA State Medical License 2023 - 2026
NY State Medical License 2020 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study.Xiongtao Yang, Xiaomin Wang, Qin Xiao, Xiaolin Ge, Nuo Yu
Cancer Biology & Therapy. 2025-12-01 - Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy.Micah Tratt, Anshu Bandhlish, Keith D Eaton, Ted Gooley, Nicholas Giustini
JTO Clinical and Research Reports. 2025-07-01 - Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapy.Nuo Yu, Yidong Wan, Lijing Zuo, Ying Cao, Dong Qu
BMC Cancer. 2025-04-02
Press Mentions
Should First-Line Dual Checkpoint Blockade Be Used for NSCLC with Specific Mutations?October 24th, 2024- Cancer Today’s Summer 2024 Issue: Cardiovascular Toxicity, Immunotherapy in NSCLC, TILs, and MoreJune 25th, 2024
- New Signateratm MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
